Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL672 (Antara, Antara (micronized), Fenofibrate, Fenofibrate delayed release, Fenofibrate micronized, Fenofibrate (micronized), Fenogal, Fenoglide, Lipantil, Lipantil micro 200, Lipantil micro 267, Lipantil micro 67, Lipidil, Lipofen, NSC-281319, Supralip 160, Tricor, Tricor (micronized), Triglide) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
acetylcholinesterase (Cartwright blood group)/Acetylcholinesterase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL220] [GtoPdb: 2465] [UniProtKB: P22303] | ||||||||
ChEMBL | DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine) | B | 4.81 | pIC50 | 15551 | nM | IC50 | DrugMatrix in vitro pharmacology data |
A3 receptor/Adenosine A3 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL256] [GtoPdb: 21] [UniProtKB: P0DMS8] | ||||||||
ChEMBL | DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) | B | 5.49 | pKi | 3222 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) | B | 5.24 | pIC50 | 5701 | nM | IC50 | DrugMatrix in vitro pharmacology data |
β3-adrenoceptor/Beta-3 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL246] [GtoPdb: 30] [UniProtKB: P13945] | ||||||||
ChEMBL | DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol) | B | 4.03 | pKi | 92959 | nM | Ki | DrugMatrix in vitro pharmacology data |
Cruzipain in Trypanosoma cruzi (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3563] [UniProtKB: P25779] | ||||||||
ChEMBL | Inhibition of Trypanosoma cruzi cruzaine preincubated for 5 mins before substrate addition by fluorescence assay in absence of Triton X-100 | B | 4.21 | pIC50 | 61000 | nM | IC50 | J Med Chem (2010) 53: 4259-4265 [PMID:20426472] |
D3 receptor/Dopamine D3 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL234] [GtoPdb: 216] [UniProtKB: P35462] | ||||||||
ChEMBL | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) | B | 4.33 | pKi | 46709 | nM | Ki | DrugMatrix in vitro pharmacology data |
DAT/Dopamine transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL238] [GtoPdb: 927] [UniProtKB: Q01959] | ||||||||
ChEMBL | DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) | B | 5.16 | pKi | 6859 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) | B | 5.06 | pIC50 | 8633 | nM | IC50 | DrugMatrix in vitro pharmacology data |
fatty acid binding protein 1/Fatty acid-binding protein, liver in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5738] [GtoPdb: 2531] [UniProtKB: P02692] | ||||||||
ChEMBL | Binding affinity to rat recombinant L-FABP low affinity site expressed in Escherichia coli BL21(DE3) at 42 deg C by fluorimetric assay | B | 6.44 | pKd | 360 | nM | Kd | J Med Chem (2009) 52: 5344-5355 [PMID:19663428] |
ChEMBL | Binding affinity to rat recombinant L-FABP low affinity site expressed in Escherichia coli BL21(DE3) at 37 deg C by fluorimetric assay | B | 6.49 | pKd | 320 | nM | Kd | J Med Chem (2009) 52: 5344-5355 [PMID:19663428] |
ChEMBL | Binding affinity to rat recombinant L-FABP low affinity site expressed in Escherichia coli BL21(DE3) at 30 deg C by fluorimetric assay | B | 6.57 | pKd | 270 | nM | Kd | J Med Chem (2009) 52: 5344-5355 [PMID:19663428] |
ChEMBL | Binding affinity to rat recombinant L-FABP low affinity site expressed in Escherichia coli BL21(DE3) at 25 deg C by fluorimetric assay | B | 6.6 | pKd | 250 | nM | Kd | J Med Chem (2009) 52: 5344-5355 [PMID:19663428] |
ChEMBL | Binding affinity to rat recombinant L-FABP low affinity site expressed in Escherichia coli BL21(DE3) at 20 deg C by fluorimetric assay | B | 6.7 | pKd | 200 | nM | Kd | J Med Chem (2009) 52: 5344-5355 [PMID:19663428] |
ChEMBL | Binding affinity to rat recombinant L-FABP low affinity site expressed in Escherichia coli BL21(DE3) at 15 deg C by fluorimetric assay | B | 6.8 | pKd | 160 | nM | Kd | J Med Chem (2009) 52: 5344-5355 [PMID:19663428] |
ChEMBL | Binding affinity to rat recombinant L-FABP low affinity site expressed in Escherichia coli BL21(DE3) at 10 deg C by fluorimetric assay | B | 6.82 | pKd | 150 | nM | Kd | J Med Chem (2009) 52: 5344-5355 [PMID:19663428] |
ChEMBL | Binding affinity to rat recombinant L-FABP low affinity site expressed in Escherichia coli BL21(DE3) at 5 deg C by fluorimetric assay | B | 6.89 | pKd | 130 | nM | Kd | J Med Chem (2009) 52: 5344-5355 [PMID:19663428] |
ChEMBL | Binding affinity to rat recombinant L-FABP high affinity site expressed in Escherichia coli BL21(DE3) at 37 deg C by fluorimetric assay | B | 7.21 | pKd | 62 | nM | Kd | J Med Chem (2009) 52: 5344-5355 [PMID:19663428] |
ChEMBL | Binding affinity to rat recombinant L-FABP high affinity site expressed in Escherichia coli BL21(DE3) at 30 deg C by fluorimetric assay | B | 7.39 | pKd | 41 | nM | Kd | J Med Chem (2009) 52: 5344-5355 [PMID:19663428] |
ChEMBL | Binding affinity to rat recombinant L-FABP high affinity site expressed in Escherichia coli BL21(DE3) at 25 deg C by fluorimetric assay | B | 7.49 | pKd | 32 | nM | Kd | J Med Chem (2009) 52: 5344-5355 [PMID:19663428] |
ChEMBL | Binding affinity to rat recombinant L-FABP high affinity site expressed in Escherichia coli BL21(DE3) at 20 deg C by fluorimetric assay | B | 7.57 | pKd | 27 | nM | Kd | J Med Chem (2009) 52: 5344-5355 [PMID:19663428] |
ChEMBL | Binding affinity to rat recombinant L-FABP high affinity site expressed in Escherichia coli BL21(DE3) at 15 deg C by fluorimetric assay | B | 7.62 | pKd | 24 | nM | Kd | J Med Chem (2009) 52: 5344-5355 [PMID:19663428] |
ChEMBL | Binding affinity to rat recombinant L-FABP high affinity site expressed in Escherichia coli BL21(DE3) at 10 deg C by fluorimetric assay | B | 7.64 | pKd | 23 | nM | Kd | J Med Chem (2009) 52: 5344-5355 [PMID:19663428] |
ChEMBL | Binding affinity to rat recombinant L-FABP high affinity site expressed in Escherichia coli BL21(DE3) at 5 deg C by fluorimetric assay | B | 7.74 | pKd | 18 | nM | Kd | J Med Chem (2009) 52: 5344-5355 [PMID:19663428] |
ChEMBL | Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP low binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay | B | 6.39 | pKi | 405 | nM | Ki | J Med Chem (2008) 51: 3755-3764 [PMID:18533710] |
ChEMBL | Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP high binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay | B | 7.62 | pKi | 24 | nM | Ki | J Med Chem (2008) 51: 3755-3764 [PMID:18533710] |
GtoPdb | - | - | 7.62 | pKi | 24 | nM | Ki | J Med Chem (2008) 51: 3755-64 [PMID:18533710] |
NET/Norepinephrine transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL222] [GtoPdb: 926] [UniProtKB: P23975] | ||||||||
ChEMBL | DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) | B | 4.67 | pKi | 21231 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) | B | 4.67 | pIC50 | 21408 | nM | IC50 | DrugMatrix in vitro pharmacology data |
Peroxisome proliferator-activated receptor-α/Peroxisome proliferator-activated receptor alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL239] [GtoPdb: 593] [UniProtKB: Q07869] | ||||||||
ChEMBL | Inhibition of human PPARalpha receptor by scintillation proximity assay | B | 6 | pIC50 | 1000 | nM | IC50 | J Med Chem (2009) 52: 4443-4453 [PMID:19530681] |
ChEMBL | Transactivation of human GAL4-fused PPARalpha LBD expressed in human HepG2 cells after 24 hrs by renilla luciferase reporter gene assay | B | 4.3 | pEC50 | 50000 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 2124-2128 [PMID:31320147] |
ChEMBL | In vitro effective concentration for agonist activity on dog Peroxisome proliferator activated receptor alpha-Gal4 chimeric receptor in transfected CHO-K1 cells | F | 4.3 | pEC50 | 50000 | nM | EC50 | J Med Chem (2003) 46: 3581-3599 [PMID:12904063] |
ChEMBL | In vitro effective concentration for agonist activity on human Peroxisome proliferator activated receptor alpha-Gal4 chimeric receptor in transfected KRP-297 cells | F | 4.39 | pEC50 | 41000 | nM | EC50 | J Med Chem (2003) 46: 3581-3599 [PMID:12904063] |
ChEMBL | Agonist activity at human PPARalpha expressed in HEK293 cells cotransfected with PPREx4-TK-luc assessed as activation of luciferase activity measured after 48 hrs by transactivation assay | B | 4.47 | pEC50 | 33510 | nM | EC50 | Bioorg Med Chem (2013) 21: 766-778 [PMID:23265844] |
ChEMBL | Agonist activity at human PPARalpha assessed as luciferase activity by transactivation assay | F | 4.47 | pEC50 | 33500 | nM | EC50 | J Med Chem (2009) 52: 6835-6850 [PMID:19807106] |
GtoPdb | In a cell based hPPAR-GAL4 transactivation assay. | - | 4.52 | pEC50 | 30000 | nM | EC50 | J Med Chem (2004) 47: 4118-27 [PMID:15293980] |
ChEMBL | Agonist activity for Human PPAR alpha receptor in transcriptional activation assay | F | 4.52 | pEC50 | 30000 | nM | EC50 | J Med Chem (2000) 43: 527-550 [PMID:10691680] |
ChEMBL | Effective concentration against human peroxisome proliferator activated receptor alpha in Gal4 transactivation assay | B | 4.52 | pEC50 | 30000 | nM | EC50 | J Med Chem (2004) 47: 4118-4127 [PMID:15293980] |
ChEMBL | Agonist activity at GAL4-fused PPARalpha LBD (unknown origin) expressed in HEK293 cells assessed as receptor transactivation after 18 hrs by dual luciferase reporter gene assay | B | 4.52 | pEC50 | 30000 | nM | EC50 | Eur J Med Chem (2017) 138: 212-220 [PMID:28667876] |
ChEMBL | Agonist activity at PPARalpha (unknown origin) | B | 4.52 | pEC50 | 30000 | nM | EC50 | J Med Chem (2020) 63: 5031-5073 [PMID:31930920] |
ChEMBL | Agonist activity at PPARalpha | F | 4.7 | pEC50 | 20000 | nM | EC50 | J Med Chem (2008) 51: 6318-6333 [PMID:18826205] |
ChEMBL | In vitro activation of human peroxisome proliferator activated receptor alpha | B | 5.49 | pEC50 | 3210 | nM | EC50 | Bioorg Med Chem Lett (2003) 13: 257-260 [PMID:12482434] |
ChEMBL | Agonist activity at human PPARalpha receptor expressed in african green monkey COS1 cells co-transfected with fused yeast Gal4-DBD by transactivation assay | F | 5.7 | pEC50 | 2000 | nM | EC50 | J Med Chem (2009) 52: 4443-4453 [PMID:19530681] |
Peroxisome proliferator-activated receptor-α/Peroxisome proliferator-activated receptor alpha in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2128] [GtoPdb: 593] [UniProtKB: P23204] | ||||||||
ChEMBL | Agonist activity for murine PPAR alpha receptor in transcriptional activation assay | F | 4.74 | pEC50 | 18000 | nM | EC50 | J Med Chem (2000) 43: 527-550 [PMID:10691680] |
Peroxisome proliferator-activated receptor-α/Peroxisome proliferator-activated receptor alpha in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2129] [GtoPdb: 593] [UniProtKB: P37230] | ||||||||
ChEMBL | In vitro effective concentration for agonist activity on rat Peroxisome proliferator activated receptor alpha-Gal4 chimeric receptor in transfected CHO-K1 cells | F | 4.31 | pEC50 | 49000 | nM | EC50 | J Med Chem (2003) 46: 3581-3599 [PMID:12904063] |
ChEMBL | Agonist activity at rat PPARalpha in rat H4IIE cells assessed as gene induction | F | 5 | pEC50 | >10000 | nM | EC50 | Bioorg Med Chem Lett (2007) 17: 6773-6778 [PMID:18029176] |
Peroxisome proliferator-activated receptor-γ/Peroxisome proliferator-activated receptor gamma in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL235] [GtoPdb: 595] [UniProtKB: P37231] | ||||||||
ChEMBL | Inhibition of human PPARgamma receptor by scintillation proximity assay | B | 5.3 | pIC50 | >5000 | nM | IC50 | J Med Chem (2009) 52: 4443-4453 [PMID:19530681] |
ChEMBL | Binding affinity at PPARgamma | B | 4.39 | pEC50 | 41000 | nM | EC50 | Bioorg Med Chem (2008) 16: 2489-2498 [PMID:18083521] |
ChEMBL | Agonist activity at human PPARgamma receptor expressed in african green monkey COS1 cells co-transfected with fused yeast Gal4-DBD by transactivation assay | F | 5.3 | pEC50 | >5000 | nM | EC50 | J Med Chem (2009) 52: 4443-4453 [PMID:19530681] |
ChEMBL | In vitro activation of human peroxisome proliferator activated receptor gamma (PPAR gamma) | B | 6.24 | pEC50 | 570 | nM | EC50 | Bioorg Med Chem Lett (2003) 13: 257-260 [PMID:12482434] |
Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364] | ||||||||
ChEMBL | Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay | F | 4.9 | pIC50 | 12589.25 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
ChEMBL | Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay | F | 4.9 | pIC50 | 12589.25 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
ChEMBL | Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay | F | 4.9 | pIC50 | 12589.25 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
ChEMBL | Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay | F | 4.9 | pIC50 | 12589.25 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
ChEMBL | Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay | F | 4.9 | pIC50 | 12589.25 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
ChEMBL | Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay | F | 5 | pIC50 | 10000 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
ChEMBL | Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay | F | 5.1 | pIC50 | 7943.28 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
5-HT2A receptor/Serotonin 2a (5-HT2a) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL224] [GtoPdb: 6] [UniProtKB: P28223] | ||||||||
ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) | B | 6.22 | pKi | 605 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) | B | 5.67 | pIC50 | 2118 | nM | IC50 | DrugMatrix in vitro pharmacology data |
5-HT2C receptor/Serotonin 2c (5-HT2c) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL225] [GtoPdb: 8] [UniProtKB: P28335] | ||||||||
ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | B | 5.91 | pKi | 1242 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | B | 5.63 | pIC50 | 2371 | nM | IC50 | DrugMatrix in vitro pharmacology data |
Urate anion exchanger 1/Solute carrier family 22 member 12 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6120] [GtoPdb: 1031] [UniProtKB: Q96S37] | ||||||||
ChEMBL | Inhibition of URAT1 (unknown origin) | B | 4.12 | pIC50 | >75000 | nM | IC50 | Medchemcomm (2016) 7: 1587-1595 |
ChEMBL data shown on this page come from version 32:
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]